Advances in the delivery of RNA therapeutics: from concept to clinical reality.
Kaczmarek JC, Kowalski PS, Anderson DG. · 2017
Read Advances in the delivery of RNA therapeutics: from concept to clinical reality. by Kaczmarek JC, Kowalski PS, Anderson DG. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5485616.txt.
Description
Kaczmarek, Kowalski, and Anderson present a review in Genome Medicine on delivering RNA drugs. RNA therapies can silence or edit disease-linked genes with high precision. Bare RNA breaks down fast, though, and cannot cross cell membranes alone. Getting it into cells safely has blocked the field for two decades. The authors survey the delivery tools now changing that.
Carriers covered include lipid and polymer nanoparticles and engineered viruses. Chemical tweaks that shield RNA from enzymes also feature. The review then maps uses in trials and labs, from gene silencing to CRISPR editing. The first RNA drugs were nearing approval at the time. Delivery remains the key bottleneck, they stress.
Catalog record
| CREATOR | Kaczmarek JC, Kowalski PS, Anderson DG. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 76 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |